Biome Financial Statements From 2010 to 2024
| BIOIF Stock | USD 0 0 48.65% |
Check Biome Grow financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biome Grow's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biome financial statements analysis is a perfect complement when working with Biome Grow Valuation or Volatility modules.
Biome |
Biome Grow Company Shares Outstanding Analysis
Biome Grow's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Biome Grow Shares Outstanding | 112.42 M |
Most of Biome Grow's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biome Grow is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Biome Grow has 112.42 M of shares currently outstending. This is 37.73% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 80.34% higher than that of the company.
Biome Grow Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biome Grow's current stock value. Our valuation model uses many indicators to compare Biome Grow value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biome Grow competition to find correlations between indicators driving Biome Grow's intrinsic value. More Info.Biome Grow is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biome Grow's earnings, one of the primary drivers of an investment's value.About Biome Grow Financial Statements
Biome Grow stakeholders use historical fundamental indicators, such as Biome Grow's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biome Grow investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biome Grow's assets and liabilities are reflected in the revenues and expenses on Biome Grow's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biome Grow. Please read more on our technical analysis and fundamental analysis pages.
Biome Grow is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Biome Pink Sheet
Biome Grow financial ratios help investors to determine whether Biome Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biome with respect to the benefits of owning Biome Grow security.